Abbott Laboratories (ABT) — closed signal from July 18, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on October 16, 2025.
Predicted vs. what happened
What happened
Hit or exceeded the predicted growth inside the window.
The thesis — published July 18, 2025
Abbott’s share price dropped after the company gave a careful outlook even though it earned more than expected. Very few traders are buying now, so the price looks unusually low. Some investors see the fall as temporary because talk of lower interest rates often steers money toward steady healthcare firms. Yet slower product roll-outs and possible rule changes for its glucose monitor could weigh on growth. A climb toward $138 could happen, but certainty is low.
Primary drivers
- The price looks beat up yet sentiment is upbeat, a mix that often fuels quick relief rallies.
- Talk of lower rates makes safe healthcare stocks more appealing to big investors right now.
- Heavy buying showed up even after the drop, signaling traders are ready to step in again.
- October earnings preview offers a timed news event that could spark renewed interest.
How it played out
ABT: target was not reached
Lyra published ABT at $123.54 on July 18, 2025. The thesis expected 12% growth toward $137.75. It pointed to a beat-up price, upbeat sentiment, rate-cut talk favoring steady healthcare stocks, heavy buying after the drop, and an October earnings preview as a possible timed catalyst.
Inside the window, ABT rose but stayed below the target. The peak was $136.88 on September 22, a 10.8% gain. It never got there. By October 16, the stock ended at $127.63. The thesis partially played out, but the published target was missed.
What happened during the window
On October 15, 2025, Abbott reported third-quarter sales of $11.37 billion and adjusted earnings of $1.30 per share. The same day, Barron's reported that Abbott narrowed its 2025 adjusted earnings guidance to $5.12 to $5.18.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.